Management of reactive arthritis in a juvenile gorilla (Gorilla gorilla gorilla) with long-term sulfasalazine therapy

Journal of Zoo and Wildlife Medicine

Volumn 31, Issue 4, 2000, Pages 539-551

  Neiffer, Donald L ^a,d   Rothschild, Bruce M ^b   Marks, Steven K ^a,e   Urvater, Julie A ^c,f   Watkins, David I ^c  

^a Pittsburgh Zoo   (United States)

^b ARTHRITIS CENTER OF NORTHEAST OHIO   (United States)

^c UNIVERSITY OF WISCONSIN   (United States)

^d Walt Disney World   (United States)

^e Elmwood Park Zoo   (United States)

^f SEED Intellectual Property Law G   (United States)

Author keywords

Gorilla gorilla gorilla; Reactive arthritis; Spondyloarthropathy; Sulfasalazine; Western lowland gorilla

Indexed keywords

ANTIRHEUMATIC AGENT; HLA ANTIGEN CLASS 1; SALAZOSULFAPYRIDINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CASE REPORT; GORILLA; GROWTH DISORDER; IMMUNOGENETICS; ISOLATION AND PURIFICATION; MALE; PRIMATE DISEASE; REACTIVE ARTHRITIS; SHIGELLA; SHIGELLOSIS;

ANIMALS; ANTIRHEUMATIC AGENTS; ARTHRITIS, REACTIVE; DYSENTERY, BACILLARY; GORILLA GORILLA; GROWTH DISORDERS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOGENETICS; MALE; PRIMATE DISEASES; SHIGELLA; SULFASALAZINE;

EID: 0034574339     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/1042-7260(2000)031[0539:MORAIA]2.0.CO;2     Document Type: Article

References (52)

1. Adams, R. F., G. S. Flinn, Jr., and M. Douglas. 1987. Ankylosing spondylitis in a nonhuman primate: a monkey tale (letter). Arthritis Rheum. 30: 956-957.
2. Banish, L. D., R. Sims, M. Bush, D. Sack, and R. J. Montali. 1993. Clearance of Shigella flexneri carriers in a zoologic collection of primates. J. Am. Vet. Med. Assoc. 203: 133-136.
3. Banish, L. D., R. Sims, D. Sack, R. J. Montali, L. Phillips, Jr., and M. Bush. 1993. Prevalence of shigellosis and other enteric pathogens in a zoologic collection of primates. J. Am. Vet. Med. Assoc. 203: 126-132.
4. Burkhardt, J. E., J. D. Eskra, F. A. Clemo, and I. G. Otterness. 1999. Effects of nalidixic acid on hamster knee cartilage morphology and synovial fluid composition. Toxicol. Pathol. 27: 421-426.
5. Burkhardt, J. E., M. A. Hill, J. J. Turek, and W. W. Carlton. 1992. Ultrastructural changes in articular cartilages of immature beagle dogs dosed with difloxacin, a fluoroquinolone. Vet. Pathol. 29: 230-238.
6. Cate, R. H., and A. Cats. 1991. Toxicity of sulfasalazine in systemic juvenile chronic arthritis. Clin. Exp. Rheumatol. 9: 85-88.
7. Clegg, D. O., D. J. Reda, M. H. Weisman, J. J. Cush, F. B. Vasey, H. R. Schumacher, Jr., E. Budiman-Mak, D. J. Balestra, W. D. Blackburn, G. W. Cannon, R. D. Inman, F. P. Alepa, E. Mejieas, M. R. Chohen, R. Makkena, M. L. Mahowald, J. Higashida, S. L. Silverman, N. Parhami, J. Buxbaum, C. M. Haakenson, R. H. Ward, B. J. Manaster, R. J. Anderson, J. R. Ward, and W. G. Henderson. 1996. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). Arthritis Rheum. 39: 2021-2027.
8. Creemers, M. C. W., P. L. C. M. van Riel, M. J. A. M. Franssen, L. B. A. van de Putte, and F. W. J. Gribnau. 1994. Second-line treatment in seronegative spondyloarthropathies. Semin. Arthritis Rheum. 24: 71-81.
9. Dougados, M., P. Boumier, and B. Amor. 1986. Sulfasalazine in ankylosing spondylitis: a double blind controlled study in 60 patients. Br. Med. J. 293: 911-914.
10. Douidar, S. M., and W. R. Snodgrass. 1989. Potential role of fluoroquinolones in pediatric infections. Rev. Infect. Dis. 11: 878-889.
11. Fitzgerald, P. A. 1997. Endocrinology. In: Tierney, L. M., Jr., S. J. McPhee, and M. A. Papadakis (eds.). Current Medical Diagnosis and Treatment. Appleton and Lange, Stamford, Connecticut. Pp. 1007-1068.
12. Gijzen, A., and J. Tijskens. 1971. Growth in weight of lowland gorilla Gorilla g. gorilla and of the mountain gorilla Gorilla g. beringei. Int. Zoo Yearb. 11: 183-193.
13. Gough, A., R. Johnson, E. Campbell, L. Hall, J. Tylor, A. Carpenter, W. Black, P. K. Basrur, V. M. Baragi, R. Sigler, and A. Metz. 1996. Quinolone arthropathy in immature rabbits treated with the fluroquinolone, PD 117596. Exp. Toxicol. Pathol. 48: 225-232.
14. Hamadeh, M. A., J. Atkinson, and L. J. Smith. 1992. Sulfasalazine-induced pulmonary disease. Chest 101: 1033-1037.
15. Hannu, T. J., and M. Leirisalo-Repo. 1988. Clinical picture of reactive Salmonella arthritis. J. Rheumatol. 15: 1668-1671.
16. Kingsley, G., J. Sieper, J. Braun, F. Chieco-Bianchi, K. Simon, and J. Heesemann. 1993. Meeting report: second international workshop on reactive arthritis. Clin. Exp. Rheumatol. 11: 229-237.
17. Lawlor, D. A., E. Warren, P. Taylor, and P. J. Parham. 1991. Gorilla class I major histocompatibility complex alleles: comparison to human and chimpanzee class I. Exp. Med. 174: 1491-1509.
18. Lawlor, D. A., E. Warren, F. E. Ward, and P. Parham. 1990. Comparison of class I MHC alleles in humans and apes. Immunol. Rev. 113: 147-185.
19. Leirisalo-Repo, M. 1993. Are antibiotics of any use in reactive arthritis? APMIS 101: 575-581.
20. McConkey, B., R. S. Amos, S. Durham, P. J. Forster, S. Hitball, and L. Walsh. 1980. Sulfasalazine I rheumatoid arthritis. Br. Med. J. 280: 442-444.
21. McEntegart, A., D. Porter, H. A. Capell, and E. A. Thomson. 1996. Sulfasalazine has a better efficacy/toxicity profile than auranofin - evidence from a 5 year prospective, randomized trial. J. Rheumotol. 23: 1887-1890.
22. Newman, E. D., J. L. Perrequet, and T. M. Harrington. 1991. Sulfasalazine therapy in psoritatic arthritis: clinical and immunologic response. J. Rheumatol. 18: 1379-1382.
23. Nissila, M., K. Lehtinen, M. Leiraisalo-Repo, R. Luukkainen, O. Mutru, and U. Yli-Kerttula. 1988. Sulfasalazine in the treatment of ankylosing spondylitis. Arthritis Rheum. 31: 1111-1116.
24. Pearl, R. K., R. L. Nelson, M. L. Prasad, C. P. Orsay, and H. Abcarian. 1986. Serious complications of sulfasalazine. Dis. Colon Rectum 29: 201-202.
25. Peppercorn, M. A. 1984. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development. Ann. Intern. Med. 101: 377-386.
26. Raphael, B. L., P. P. Calle, N. Haramati, D. I. Watkins, M. D. Stetter, and R. A. Cook. 1995. Reactive arthritis subsequent to Shigella flexneri enteritis in two juvenile lowland gorillas (Gorilla gorilla gorilla). J. Zoo Wildl. Med. 26: 132-138.
27. Ribe, J., K. J. Benkov, S. N. Thung, S. C. Shen, and N. S. LeLeiko. 1986. Fatal massive hepatic necrosis: a probable hypersensitivity reaction to Sulfasalazine. Am. J. Gastroenterol. 81: 205-208.
28. Rothschild, B. M. 1993. Arthritis of the spondyloarthropathy variety in Callithrix jacchus. J. Med. Primatol. 22: 313-316.
29. Rothschild, B. M. 1994. Reactive arthritis and Reiter's syndrome. Compr. Ther. 20: 441-444.
30. Rothschild, B. M., N. Hong, and J. E. Turnquist. 1997. Naturally occurring inflammatory arthritis of the spondyloarthropathy variety in Cayo Santiago rhesus macaques (Macaca mulatta). Clin. Exp. Rheumatol. 15: 45-51.
31. Rothschild, B. M., and C. Rothschild. 1994. No laughing matter: spondyloarthropathy and osteoarthritis in Hyaenidae. J. Zoo Wildl. Med. 25: 259-263.
32. Rothschild, B. M., C. Rothschild, and R. J. Woods. 1998. Inflammatory arthritis in large cats: an expanded spectrum of spondyloarthropathy. J. Zoo Wildl. Med. 29: 279-284.
33. Rothschild, B. M., X. Wang, and R. Cifelli. 1993. Spondyloarthropathy in Ursidae: a sexually transmitted disease? Natl. Geogr. Res. Explor. 9: 382-384.
34. Rothschild, B. M., X. Wang, and J. Shoshani. 1994. Spondyloarthropathy in proboscideans. J. Zoo Wildl. Med. 25: 360-366.
35. Rothschild, B. M., and R. J. Woods. 1989. Spondyloarthropathy in gorillas. Semin. Arthritis Rheum. 18: 267-276.
36. Rothschild, B. M., and R. J. Woods. 1991. Reactive erosive arthritis in chimpanzees. Am. J. Primatol. 25: 49-56.
37. Rothschild, B. M., and R. J. Woods. 1991. Spondyloarthropathy: erosive arthritis in representative defleshed bones. Am. J. Phys. Anthropol. 85: 125-134.
38. Rothschild, B. M., and R. J. Woods. 1992. Implication of osseous changes for the diagnosis of spondyloarthropathy. J. Orthop. Rheum. 5: 155-162.
39. Rothschild, B. M., and R. J. Woods. 1992. Spondyloarthropathy as an old world phenomenon. Semin. Arthritis Rheum. 21: 306-316.
40. Rothschild, B. M., and R. J. Woods. 1993. Arthritis in new world monkeys: osteoarthritis, calcium pyrophosphate deposition disease, and spondyloarthropathy. Int. J. Primatol. 14: 61-78.
41. Rothschild, B. M., and R. J. Woods. 1996. Inflammatory arthritis in Pongo. J. Med. Primatol. 25: 414-418.
42. Salerno, S. M., E. J. Ormseth, B. J. Roth, C. A. Meyer, E. D. Christensen, and T. A. Dillard. 1996. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegner's granulomatosis. Chest 110: 556-559.
43. Schaad, U. B., C. Stoupis, J. Wedgwood, H. Tschaeppeler, and P. Vock. 1991. Clinical, radiologic and magnetic resonance monitoring for skeletal toxicity in pediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr. Infect. Dis. J. 10: 723-729.
44. Schaad, U. B., and J. Wedgwood-Krucko. 1987. Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity. Infection 15: 165-168.
45. Simon, D. G., R. A. Kaslow, J. Rosenbaum, R. L. Kaye, and A. Calin. 1981. Reiter's syndrome following epidemic shigellosis. J. Rheumatol. 8: 969-973.
46. Stetter, M. D., R. A. Cook, P. P. Calle, H. Shayegani, and B. L. Raphael. 1995. Shigellosis in captive western lowland gorillas (Gorilla gorilla gorilla). J. Zoo Wildl. Med. 26: 52-60.
47. Stieglitz, H., S. Fosmire, and P. Lipsky. 1989. Identification of a 2-Md plasmid from Shigella flexneri associated with reactive arthritis. Arthritis Rheum. 32: 937-946.
48. Taurog, J. D., and P. E. Lipsky. 1994. Ankylosing spondylitis, reactive arthritis, and undifferentiated spoil-dyloarthropathy. In: Isselbacher, K. J., E. Braunwald, J. D. Wilson, J. B. Martin, A. S. Fauci, and D. L. Kasper (eds.). Harrison's Principles of Internal Medicine, 13th ed. McGraw-Hill, Inc., New York, New York. Pp. 1664-1669.
49. Urvater, J. A., H. Hickman, K. Prilliman, T. M. Allen, K. J. Schwartz, E. J. Collins, J. L. Dzuris, A. Sette, D. Lorentzen, C. Shufflebotham, W. Hildebrand, D. L. Neiffer, B. Raphael, and D. I. Watkins. In press. Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence to HLA-B27 that binds peptides with arginine at P2. J. Immunol.
50. Wang, K. K., B. A. Bowyer, C. R. Fleming, and K. W. Schroeder. 1984. Pulmonary infiltrates and eosinophilia associated with sulfasalazine. Mayo Clin. Proc. 59: 343-346.
51. Yoshida, K., K. Yabe, S. Nishida, N. Yamamoto, C. Ohshima, M. Sekiguchi, K. Yamada, and K. Furuhama. 1998. Pharmacokinetic disposition and arthropathic potential of oral ofloxacin in dogs. J. Vet. Pharmacol. Ther. 21: 128-132.
52. Zwillich, S. H., S. S. Comer, E. Lee, W. A. Erdman, and P. E. Lipsky. 1988. Treatment of the seronegative spondyloarthropathies with sulfasalazine. J. Rheumatol. 15(Suppl. 16): 33-39.